NATIONAL HEALTHCARE CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NATIONAL HEALTHCARE CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.52B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.31B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.14B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.09B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.07B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.03B | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $253.88M | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | $247.07M | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | $247.15M | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | $248.29M | Feb 21, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $120.02M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $101.93M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $66.80M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $22.45M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $138.59M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $41.87M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $68.21M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $58.96M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $56.21M | Feb 21, 2020 |
| FY2016 | Dec 31, 2016 | $13.86M | Feb 15, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $128.35M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $89.90M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $57.46M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $31.90M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $50.93M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $48.16M | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $16.50M | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | $6.57M | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | $10.19M | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | $15.78M | Feb 21, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $185.08M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $107.30M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $111.22M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $8.74M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $62.39M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $203.26M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $100.10M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $98.44M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $94.47M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $90.88M | Feb 20, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.45M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $27.60M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $27.90M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $30.20M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $39.40M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $21.87M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $26.40M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $29.77M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $32.35M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $62.60M | Feb 20, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.53B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.52B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.31B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.28B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.40B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.36B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.29B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.08B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $1.10B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $1.09B | Feb 20, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $451.90M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $541.27M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $400.32M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $397.94M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $494.94M | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $563.87M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $507.58M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $346.49M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $393.09M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $417.84M | Feb 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.07B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $980.16M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $908.75M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $874.28M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $903.00M | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $795.18M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $778.59M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $733.28M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $702.74M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $669.61M | Feb 20, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $170.48M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $170.48M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $168.30M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $168.30M | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | $168.30M | Feb 17, 2023 |
| FY2022 | Dec 31, 2020 | $21.34M | Feb 17, 2023 |
| FY2022 | Dec 31, 2019 | $21.00M | Feb 17, 2023 |
| FY2021 | Dec 31, 2018 | $21.00M | Feb 18, 2022 |
| FY2018 | Dec 31, 2017 | $17.60M | Feb 20, 2019 |
| FY2018 | Dec 31, 2016 | $17.60M | Feb 20, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $832.98M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $752.19M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $687.60M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $656.66M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $669.08M | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $563.02M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $553.09M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $516.44M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $419.42M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $391.93M | Feb 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $92.83M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $76.12M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $107.08M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $58.67M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $107.61M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $147.09M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $50.33M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $43.25M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $59.12M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $26.34M | Feb 20, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2024 | $137.00M | Mar 3, 2025 |
| FY2019 | Dec 31, 2019 | $10.00M | Feb 21, 2020 |
| FY2018 | Dec 31, 2018 | $55.00M | Feb 20, 2019 |
| FY2018 | Dec 31, 2017 | $100.00M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $120.00M | Feb 20, 2018 |
| FY2016 | Dec 31, 2015 | $120.00M | Feb 15, 2017 |
| FY2015 | Dec 31, 2014 | $10.00M | Feb 19, 2016 |
| FY2013 | Dec 31, 2013 | $10.00M | Feb 21, 2014 |
| FY2013 | Dec 31, 2012 | $10.00M | Feb 21, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 9 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | 90 | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 21, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | 89 | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 21, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15.54M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 15.45M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 15.35M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | 15.36M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | 15.45M | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | 15.37M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | 15.33M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 15.26M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | 15.21M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | 15.16M | Feb 20, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.70M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $36.96M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $35.56M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $34.60M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $32.03M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $31.92M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $31.21M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $29.83M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $28.24M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $25.80M | Feb 20, 2019 |